Immunogen stock forecast.
Analyst Price Forecast Suggests 20.07% Downside As of November 27, 2023, the average one-year price target for Immunogen is 23.46. The forecasts range from a low of 14.14 to a high of $29.40.
ImmunoGen (IMGN): At the ... Its second-quarter results showed a Non-GAAP earnings-per-share of $5, effortlessly outpacing predictions by 51 cents. Its revenues also touched $6.98B, marking a 5.9% ...Track Immunogen, Inc. (IMGN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsImmunoGen Stock Soars 80% on AbbVie’s $10.1 Billion Takeover. ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast.Dec 1, 2023 · Analyst Price Forecast Suggests 20.07% Downside As of November 27, 2023, the average one-year price target for Immunogen is 23.46. The forecasts range from a low of 14.14 to a high of $29.40. How much will ImmunoGen stock be worth in 2023? Target price in 2023. ... ImmunoGen (IMGN) stock consensus forecasts for 2023. Last update: 01/16/2023, 04:26 AM ...
May 3, 2023 · What happened. Shares of ImmunoGen (NASDAQ: IMGN) were up by 139% Wednesday morning after the company announced positive trial data concerning an ovarian cancer drug the company has in its ... ImmunoGen appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Previously a turnaround stock, ImmunoGen has come a long way with the accelerated Elahere approval. ... Check out some of our binary event forecasts that lead to meteoric gain like the 359% single ...
Dec. 4, 2023, 10:44 AM. AbbVie Inc (NYSE:ABBV) is acquiring ImmunoGen, Inc. (NASDAQ:IMGN) for around $10 billion. The deal, which is expected to close in mid …What are analysts forecasts for ImmunoGen stock? The 32 analysts offering price forecasts for ImmunoGen have a median target of 19.07, with a high estimate of 31.26 and a low estimate of 4.00. Nov 30, 2023 · Immunogen Stock (NASDAQ:IMGN), Analyst Ratings, Price Targets, Predictions benzinga.com - November 3 at 10:32 PM Strong Revenue Performance and Promising Future Developments Justify Buy Rating for ImmunoGen: An Analysis markets.businessinsider.com - November 3 at 10:32 PM 9 Wall Street analysts have issued 12-month price targets for ImmunoGen's shares. Their IMGN share price targets range from $16.00 to $28.00. On average, they expect the company's share price to reach $22.00 in the next year. This suggests a …
Nov 1, 2023 · Follow ImmunoGen stock price in real-time on Markets Insider here. ... With regard to the current fiscal year, analysts forecast a loss per share of $0.044. Last year it was $-0.880 per share. In ...
The analysts are definitely expecting ImmunoGen's growth to accelerate, with the forecast 22% annualised growth to the end of 2023 ranking favourably alongside historical growth of 6.2% per annum ...
Shares of NASDAQ:IMGN opened at $29.32 on Monday. The stock's 50 day moving average is $15.71 and its 200-day moving average is $16.33. ImmunoGen, Inc. has a twelve month low of $3.61 and a twelve month high of $29.44. The firm has a market capitalization of $7.81 billion, a price-to-earnings ratio of -94.58 and a beta of 1.21.The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. ... ImmunoGen Stock Soars 81% on AbbVie’s $10.1 Billion Takeover.Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927).Immunogen Stock Forecast Over the next 52 weeks, Immunogen has on average historically risen by 52.3% based on the past 33 years of stock performance. Immunogen has risen higher in 18 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%Analyst projections state that IMGN is forecast to be at a low of $14.00 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -74.78% from its current level, while the stock would need to crash 12.61% from its current level to reach the projected low.Nov 30, 2023 · Analyst Price Forecast Suggests 46.08% Upside As of November 27, 2023, the average one-year price target for Immunogen is 23.46. The forecasts range from a low of 14.14 to a high of $29.40.
Immunogen (IMGN) Stock Key Data. Summary Additional Data Analysts Historical Quotes. ... Bad news from the FDA sends ImmunoGen lower and J. Crew's forecast gets Bronx cheers. WATCH. Aug 27, 2010.Dec 1, 2023 · Analyst Forecast. According to 12 analysts, the average rating for IMGN stock is "Buy." The 12-month stock price forecast is $23.93, which is a decrease of -18.38% from the latest price. View the latest Immunogen Inc. (IMGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. How much is Immunogen stock worth today? ( NASDAQ: IMGN) Immunogen currently has 266,264,274 outstanding shares. With Immunogen stock trading at $16.06 per share, the total value of Immunogen stock (market capitalization) is $4.28B. Immunogen stock was originally listed at a price of $0.84 in Dec 31, 1997.The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. ... ImmunoGen Stock Soars 80% on AbbVie’s $10.1 Billion Takeover.
ImmunoGen stock was soaring Thursday following an announcement that biopharmaceutical company AbbVie has agreed to buy the cancer treatment developer for $10.1 billion. Under the terms of the sale ...
Six other stocks have also bested NVDA stock, including MoonLake Immunotherapeutics , IonQ , AppLovin , Riot Platforms , ImmunoGen , Arlo Technologies . All of these stocks have market caps of at ...AbbVie has agreed to acquire ImmunoGen in a $10.1 billion ... Please be aware of the risks associated with these stocks. ... Let’s see what will change in the forecast relating to replacing the ...A high-level overview of ImmunoGen, Inc. (IMGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...ImmunoGen Stock Soars 80% on AbbVie’s $10.1 Billion Takeover. ... and mortgage rates will average 6.8% in the new year, according to Realtor.com’s forecast published on Wednesday.Earnings per share estimates for Ligand Pharmaceuticals have gone up from $4.15 to $4.16 for 2023 and from $4.28 to $4.58 for 2024 in the past 60 days. Shares of LGND have gained 2.5% in the past ...Nov 28, 2023 · Analyst projections state that IMGN is forecast to be at a low of $14.00 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -73.27% from its current level, while the stock would need to crash 13.37% from its current level to reach the projected low. ImmunoGen Stock Soars 80% on AbbVie’s $10.1 Billion Takeover. ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast.
9 Wall Street analysts have issued 12-month price targets for ImmunoGen's shares. Their IMGN share price targets range from $16.00 to $28.00. On average, they expect the company's share price to reach $22.00 in the next year. This suggests a …
ImmunoGen Stock Soars 80% on AbbVie’s $10.1 Billion Takeover. ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast.
ImmunoGen appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Immunogen share forecasts, stock quote and buy / sell signals below. According to present data Immunogen's IMGN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The ImmunoGen stock forecast for tomorrow is $ 15.00, which would represent a 0.28% gain compared to the current price. In the next week, the price of IMGN is expected to increase by 4.03% and hit $ 15.56. As far as the long-term ImmunoGen stock forecast is concerned, here’s what our ... AbbVie (ABBV) offers to acquire cancer biotech Immunogen for $10.1 billion. Novartis (NVS) raises its mid-term sales growth outlook by 1%. Find the latest ImmunoGen, Inc. (IMGN) stock quote ... ImmunoGen stock was soaring Thursday following an announcement that biopharmaceutical company AbbVie has agreed to buy the cancer treatment developer for $10.1 billion. Under the terms of the sale ...ImmunoGen Stock Soars 80% on AbbVie’s $10.1 Billion Takeover. ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast.Find the latest analyst research for ImmunoGen, Inc. Common Stock (IMGN) at Nasdaq.com.Nov 29, 2023 · The ImmunoGen stock price gained 0.623% on the last trading day (Monday, 27th Nov 2023), rising from $16.06 to $16.16. During the last trading day the stock fluctuated 3.16% from a day low at $15.84 to a day high of $16.34. The price has been going up and down for this period, and there has been a 9.49% gain for the last 2 weeks. Mar 1, 2023 · Net loss for the year ended December 31, 2022 was $222.9 million, or $0.88 per diluted share, compared to a net loss of $139.3 million, or $0.68 per diluted share, for the year ended December 31, 2021 . ImmunoGen had $275.1 million in cash and cash equivalents as of December 31, 2022, compared with $478.8 million as of December 31, 2021. Oct 31, 2023 · The ImmunoGen stock prediction results are shown below and presented as a graph, table and text information. ImmunoGen stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for ImmunoGen analysts is $ 23. Today 200 Day Moving Average is the support level (11.53 $). ImmunoGen (NASDAQ: IMGN) is one of the better biotech stocks that you can buy today. The company’s stock is up 215% in 2023, and that’s even after a slight dip over the last two months ...With the interplay of data, predictions, and real-time performance, ImmunoGen's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.
Based on 9 Wall Street analysts offering 12 month price targets for ImmunoGen in the last 3 months. The average price target is $22.25 with a high forecast of $28.00 and a low forecast of $14.00. The average price target represents a 38.11% change from the last price of $16.11. Highest Price Target $28.00. Average Price Target $22.25. Find the latest analyst research for ImmunoGen, Inc. Common Stock (IMGN) at Nasdaq.com.The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. ... ImmunoGen Stock Soars 81% on AbbVie’s $10.1 Billion Takeover.Instagram:https://instagram. remark holdings stockdodge and cox international stockus coins value quarter dollartop 5 health insurance companies in florida Charley Grant. , Reporter. Big pharma’s $10.1 billion deal splash is giving biotech stocks a lift. AbbVie, which sells widely-used drugs like Humira and Skyrizi, said Thursday it plans to buy ... aapl target pricebest wallet for nft Oct 15, 2020 · The Immunogen stock forecast is 20.145677807197 USD for 2024 November 27, Wednesday; and 43.674 USD for 2028 November 27, Monday with technical analysis. Immunogen (IMGN) stock price prediction is 20.145677807197 USD. what is the best crypto ira The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. ... ImmunoGen Stock Soars 80% on AbbVie’s $10.1 Billion Takeover.Mar 20, 2023 · ImmunoGen stock was soaring Thursday following an announcement that biopharmaceutical company AbbVie has agreed to buy the cancer treatment developer for $10.1 billion.